secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0001213900-24-061529
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionomics receives Nasdaq bid price deficiency notice; has until Jan 7, 2025 to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Bionomics on July 11, 2024 that its ADS bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Jan 7, 2025) to regain compliance by maintaining $1.00 closing bid for 10 consecutive days.
- If not cured by Jan 7, 2025, Bionomics may qualify for a second 180-day period by meeting other listing standards and announcing a reverse stock split plan.
- Failure to cure or qualify for extension could result in delisting from The Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/0001213900-24-061529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/ea0209330-8k_bionomic.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-061529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer